company

BIOENVISION AS

3936 PORSGRUNN

Return on Equity
−190,7 %
Current Ratio
0,45
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue810 000
Net Income−62 992 000
Total Assets33 756 000
Total Equity33 032 000
Income (NOK)2022
Revenue810 000
Expenditure9 492 000
Operating Profit−8 682 000
Financial Income768 000
Financial Costs55 078 000
Financial Balance−54 310 000
Earnings Before Tax−62 992 000
Tax0
Net Income−62 992 000
Balance (NOK)2022
Total Fixed Assets33 433 000
Total Current Assets323 000
Total Assets33 756 000
Total Retained Equity−63 765 000
Total Equity33 032 000
Total Long-Term Debt0
Total Current Debt724 000
Total Equity and Debt33 756 000
Cash flow (NOK)2022
Sales Income810 000
Other Income0
Revenue810 000
Cost of Goods Sold98 000
Salary Costs2 471 000
Depreciation0
Impairment0
Expenditure9 492 000
Operating Profit−8 682 000
Financial Income768 000
Financial Costs55 078 000
Financial Balance−54 310 000
Dividends0
Net Income−62 992 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets33 433 000
Total Fixed Assets33 433 000
Stock0
Total Investments0
Cash, Bank212 000
Total Current Assets323 000
Total Assets33 756 000
Total Equity33 032 000
Short-Term Group Debt41 000
Total Long-Term Debt0
Creditors90 000
Unpaid Taxes127 000
Dividends0
Other Current Debt466 000
Total Current Debt724 000
Total Equity and Debt33 756 000
Financial indicators2022
Return on Equity−190,7 %
Debt-to-Equity Ratio0
Operating Profit Margin−1 071,85 %
Current Ratio0,45
Quick Ratio0,45
Equity Ratio0,98
Gross Profit Margin87,9 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English